Details of the Drug Reposition

General Information of This Drug (ID: DMIWL5P)

Drug Name
SAL-200   DMIWL5P

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bacteremia DIS6N9RZ 1A73 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Staphylococcus infection DISY8WGS 1B5Y Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03089697) Phase IIa Clinical Study of N-Rephasin SAL200. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01855048) A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin SAL200 in Healthy Male Volunteers. U.S. National Institutes of Health.